EHU135461
MISSION® esiRNA
targeting human INSL3
製品名
MISSION® esiRNA, targeting human INSL3
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TCAGTGGCTGTACCCAACAAGACCTGCTGACCCTCTGTCCCTACTGATTCCTCCTTGGGTGCAGCCTCAGAGTGGCCTGAGGCCCAGAGGGTCTGGTCTGGTGAGCTCCTGAGGCCACACAGCACCATAAAGTCTCGCATCTACAGGCCTTTGATTACCTCCTGGGATGGGTGCTCACTATCTACCCCAGACCAATGCCACCTGCAGCCTGTGGAGTCAACTGCAGAATAAATCACACCCTAGCCCTGGCTTGGAGGATCCCCGCTTTCACAGATGCTGGACACTGACAGCCAAATGTCCTCAC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... INSL3(3640), JAK3(3718)
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
保管分類
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Nina A Sibbesen et al.
Oncotarget, 6(24), 20555-20569 (2015-08-06)
Aberrant activation of Janus kinase-3 (Jak3) and its key down-stream effectors, Signal Transducer and Activator of Transcription-3 (STAT3) and STAT5, is a key feature of malignant transformation in cutaneous T-cell lymphoma (CTCL). However, it remains only partially understood how Jak3/STAT
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）